More importantly, subjects with known steatosis are associated with abnormal carotid intima-media [25], more vulnerable coronary plaques by MDCT [26], higher serum markers of inflammation [27], worse endothelial function, increased myocardial insulin resistance [28], decreased adiponectin concentrations, and abnormal lipoprotein metabolism [29–31]. This evidence concerns the gene ADIPOQ and steatosis.